Mesenchymal Stromal Cells A Novel Treatment Modality for Tissue Repair

被引:224
作者
Bernardo, Maria Ester [2 ]
Locatelli, Franco [2 ]
Fibbe, Willem E. [1 ]
机构
[1] Leiden Univ, Med Ctr, Ctr Stem Cell Therapy, Dept Immunohematol & Blood Transfus, NL-2333 ZA Leiden, Netherlands
[2] Univ Pavia, Policlin San Matteo, Fdn IRCCS, I-27100 Pavia, Italy
来源
HEMATOPOIETIC STEM CELLS VII | 2009年 / 1176卷
关键词
mesenchymal stem cells (MSCs); cell therapy; autoimmunity; HUMAN-BONE-MARROW; VERSUS-HOST-DISEASE; HEMATOPOIETIC STEM-CELLS; PROLIFERATION IN-VITRO; PROGENITOR CELLS; CORD BLOOD; IMMUNOSUPPRESSIVE PROPERTIES; CLINICAL-APPLICATIONS; EXPERIMENTAL COLITIS; HEALTHY DONORS;
D O I
10.1111/j.1749-6632.2009.04607.x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Mesenchymal stromal cells (MSCs) are multipotent cells that can be isolated from several human-tissues and expanded ex vivo for clinical use. MSCs are identified by their adherent properties, immunephenotype, and differentiation potential. MSCs display immunological properties that have been demonstrated both in vitro and in vivo, in animal models and in humans, although the exact mechanisms underlying these effects remain largely unknown. MSCs preferentially home to damaged tissue and secrete paracrine factors with anti-inflammatory properties. The immunomodulatory and reparative and anti-inflammatory properties of MSCs have been tested in a variety of animal models and have been applied in specific clinical settings. Potential clinical applications of MSCs include prevention and treatment of therapy-resistant acute graft-versus-host disease, prevention and treatment of rejection after either hematopoieitc stem cell and solid organ transplantation, tissue repair, and treatment of inborn errors and autoimmune diseases. This review focuses on recent advances that have broadened our understanding of the biological and functional properties of MSCs, which are increasingly attracting the attention of researchers involved in the optimization of approaches for reparative and regenerative cell therapy, as well as in the perspective of modulating immune response against alloantigens or, even, autoantigens.
引用
收藏
页码:101 / 117
页数:17
相关论文
共 132 条
  • [1] Human mesenchymal stem cells modulate allogeneic immune cell responses
    Aggarwal, S
    Pittenger, MF
    [J]. BLOOD, 2005, 105 (04) : 1815 - 1822
  • [2] Cotransplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero
    Almeida-Porada, G
    Flake, AW
    Glimp, HA
    Zanjani, ED
    [J]. EXPERIMENTAL HEMATOLOGY, 1999, 27 (10) : 1569 - 1575
  • [3] Nonhematopoietic/endothelial SSEA-1+ cells define the most primitive progenitors in the adult murine bone marrow mesenchymal compartment
    Anjos-Afonso, Fernando
    Bonnet, Dominique
    [J]. BLOOD, 2007, 109 (03) : 1298 - 1306
  • [4] Anker PSI, 2003, HAEMATOLOGICA, V88, P845
  • [5] Mesenchymal stem cells in perichondrium express activated leukocyte cell adhesion molecule and participate in bone marrow formation
    Arai, F
    Ohneda, O
    Miyamoto, T
    Zhang, XQ
    Suda, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (12) : 1549 - 1563
  • [6] Failure of adult marrow-derived stem cells to generate marrow stroma after successful hematopoietic stem cell transplantation
    Awaya, N
    Rupert, K
    Bryant, E
    Torok-Storb, B
    [J]. EXPERIMENTAL HEMATOLOGY, 2002, 30 (08) : 937 - 942
  • [7] Cotransplantation of ex vivo-expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation
    Ball, Lynne M.
    Bernardo, Maria Ester
    Roelofs, Helene
    Lankester, Arjan
    Cometa, Angela
    Egeler, R. Maarten
    Locatelli, Franco
    Fibbe, Willem E.
    [J]. BLOOD, 2007, 110 (07) : 2764 - 2767
  • [8] Mesenchymal stem cells: clinical applications and biological characterization
    Barry, FP
    Murphy, JM
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (04) : 568 - 584
  • [9] Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo
    Bartholomew, A
    Sturgeon, C
    Siatskas, M
    Ferrer, K
    McIntosh, K
    Patil, S
    Hardy, W
    Devine, S
    Ucker, D
    Deans, R
    Moseley, A
    Hoffman, R
    [J]. EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) : 42 - 48
  • [10] Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1
    Battula, Venkata Lokesh
    Treml, Sabrina
    Bareiss, Petra M.
    Gieseke, Friederike
    Roelofs, Helene
    de Zwart, Peter
    Mueller, Ingo
    Schewe, Bernhard
    Skutella, Thomas
    Fibbe, Willem E.
    Kanz, Lothar
    Buehring, Hans-Joerg
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (02): : 173 - 184